Neuland Labs gets USFDA EIR for Pashamylaram Manufacturing Facility
Hyderabad: Neuland Labs has received an Establishment Inspection Report (EIR) from the U.S.FDA for its manufacturing facility located at Pashamylaram, Hyderabad.
"The facility was inspected from 3 rd to 7th February 2020. The inspection has now been closed by the U.S. FDA," the company confirmed in a BSE filing
Neuland Laboratories Limited was established in 1984 and is a publicly listed company headquartered in Hyderabad, India.
The company produces active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs.
Next Story
